Training grants

Training grants for PhD students, instructors, and assistant professors

T32 Program

Directors: Michael R. Blackburn, PhD, and Michelle C. Barton, PhD
Contact Person: Ashley J. Hood, PhD 713-500-9874

The CCTS T32 program provides stipends for PhD students whose dissertation research is clearly translational or addresses a problem that has direct clinical implications. The program also offers didactic courses, seminars, and other training activities. The goal of the program is to train truly interdisciplinary researchers by a meaningful blending of programs and disciplines that have been traditionally operated as stand-alone entities within UT-Health schools and M. D. Anderson Cancer Center.

Eligibility and Criteria

The program provides up to 3 years of support for stipends, tuition, benefits, and travel, with the following criteria:

  • The program is open to PhD students in The University of Texas Graduate School of Biomedical Sciences at Houston (GSBS) and UT-Health School of Public Health (SPH), School of Nursing (SON), and School of Biomedical Informatics (SBMI)
  • and to MD/PhD and DDS/PhD students during the time they are enrolled in GSBS for the PhD portion of their training.
  • Stipends are most often provided to students who have already selected a doctoral dissertation project, but under special circumstances stipend support will be considered for beginning doctoral students (i.e., those without a master’s degree) who wish to design an individualized, dual-degree curriculum in which they receive the MS from one UT Health school and the PhD from another (this option requires acceptance by both participating schools).
  • In addition to students pursuing a PhD via the traditional pathway in one of the schools noted above, applications are also welcomed from students pursing the PhD who:
    • Have (or are about to complete) an MS degree in a biomedical or related discipline different from the one in which they will pursue the PhD
    • Already hold a professional degree (MPH, MD, DDS, MS in Nursing, etc.)
    • Already have a master's degree from a type of institution (e.g., a school of public health) different from the type of institution (e.g., graduate school of nursing) in which they are now pursing the doctorate.
  • Stipends are only available to U.S. citizens or permanent residents, but all GSBS and UT Health students may participate in other T32 program activities with permission. NIH regulations do not permit the provision of stipends for students pursuing a professional degree or for students in dual-degree programs (e.g., MD/PhD or DDS/PhD) while they are enrolled in the professional school portion of their training. 
  • One hundred percent professional effort must be devoted to this award; no other grant salary support or outside professional employment is allowed.

Applying to the T32 Program

THE T32 PROGRAM IS CURRENTLY ACCEPTING APPLICATIONS.

DEADLINE FOR SUBMISSION IS AUGUST 15 2013

See gsbs.uth.edu/ccts-tl1/application-renewal for more information

Applications for T32 stipend support are solicited once each year.

Appointments to the training grant are for a minimum of 12 months with an option of competitive renewals for a maximum of 3 years contingent upon annual reviews to evaluate performance and meeting program expectations.

All trainees receiving stipend support are expected to develop a curriculum/training plan that will enable them to obtain core competencies in clinical and translational research. These competencies are obtained by conducting dissertation research, completing clinical and translational courses offered by participating CCTS schools and institutions, and participating in seminars, internships, research retreats, and other activities that provide training in clinical and translational research. Trainees receiving stipend support also have access to the CCTS Core Laboratories and other CCTS services to support their dissertation research.

Courses and other activities are open to all UT-Health and M. D. Anderson Cancer Center trainees and are not limited to individuals receiving stipend support. Certain activities may also be open to part-time, non-degree, or other special students at UT-Health, M. D. Anderson Center, and other TMC institutions. Please note that an employee of any TMC institution may register in GSBS as a non-degree student for one course each semester with the permission of his or her supervisor and the approval of the course director and Deans of GSBS.    

For more information on eligibility for stipend support, application deadlines, or participating in other T32 or CCTS-related courses or activities, please contact Ashley J. Hood, PhD 713-500-9874.

For additional information about doctoral programs available in UT-Health schools, please see the following links

or contact Dr. Goode. 

Year 1

Name/Program

Affiliation

Project

Mentor

Jennifer Hsing
MD/PhD Program
Cancer Biology
Cancer Biology
UTMDACC
The Role of Endoplasmic Reticulum Stress in Pancreatic Cancer Craig Logsdon, PhD
Ashley Hood Jagar
PhD Program
Neuroscience
Neurobiology
UTHealth
Medical School
Attention and Deep Brain Stimulation in Parkinson’s Disease Ann Sereno, PhD
Emily Jen
MD/PhD Program
Molecular Biology
Experimental Therapeutics UTMDACC IL-2 Treatment Leads to Upregulation of IL-24 and Tumor Growth Suppression in Melanoma Patients Elizabeth Grimm, PhD
Pavel Levin
MD/PhD Program
Cancer Biology
Cancer Biology
UTMDACC
Role of EphA Receptors in Pancreatic Cancer Progression and Metastasis Craig Logsdon. PhD
Qian Liu
PhD Program
Human and Molecular Genetics
Epidemiology
UTMDACC
SEL1L as a biomarker for Early Detection of Pancreatic Adenocarcinoma Marsha Frazier, PhD
John McAuliffe
MD/PhD Program
Sarcoma Medical
Oncology
UTMDACC
Vascular Cytokines and Mechanisms of Imantinib in G1ST John Trent, MD, PhD
Debra Smith
MD/PhD Program
Molecular Biology
Systems Biology
UTMDACC
Characterization of Akt Feedback Signaling in Human Cancer Cell Lines Gordon Mills, MD, PhD
Hui Song
PhD Program
Cancer Biology
Molecular & Cellular
Oncology UTMDACC
VISA to Cancer Gene Therapy Mien Chie Hung, PhD

Year 2

Name/Program

Department

Project

Mentor

Kedryn Baskin
Ph.D. Program
Cell and Regulatory Biology
Internal Medicine –
Cardiology
UTHealth Medical School
AMP-activated Protein Kinase Regulates Ubiquitin Ligases in Cardiomyocyte Heinrich Taegtmeyer M.D., Ph.D.
Jennifer Hsing Choe
M.D./Ph.D. Program
Cancer Biology
Cancer Biology
UTMDACC
The Role of endoplasmic Reticulum Stress in Pancreatic Cancer Craig Logsdon, Ph.D.
Hatice Duzkale
Ph.D. Program
Genes and Development
Hematophathology
UTMDACC
Identification of the Role of LDOC1 in the Pathogenesis of Chronic Lymphocytic Leukemia (CLL) Lynne V. Abruzzo, M.D., Ph.D.
Audrey Ester
Ph.D. Program
Human and Molecular Genetics
Pediatrics
UTHealth Medical School
Defining the Role of Apoptotic and Hox Genes in the Development of Clubfoot Jacqueline Hecht, Ph.D.
Ashley J. Hood
Ph.D. Program
Neurosciences
Neurobiology
UTHealth Medical School
The Effect of Deep Brain Stimulation on Attention in Parkinson Disease Anne B. Sereno, Ph.D.
Lenka Hurton
Ph.D. Program
Immunology
Immunology
UTMDACC
Improving persistence of tumor-specific T cells by augmenting signaling in concert with immunoreceptor for improved therapeutic efficacy Laurence J.N. Cooper, M.D., Ph.D.
Cameron Jeter
Ph.D. Program
Neuroscience
Neurobiology
UTHealth Medical School
Reflexive and Voluntary Eye Movements in Tourette Syndrome Anne B. Sereno, Ph.D.
Pavel Levin
M.D./Ph.D. Program
Cancer Biology
Cancer Biology
UTMDACC
Role of EphA2 Receptor in Pancreatic Cancer Progression and Metastasis Craig Logsdon, Ph.D.
Keri Schadler
Ph.D. Program
Cancer Biology
Cancer Biology
UTMDACC
The Role of Delta-like Ligand 4 in Vasculogenesis in Ewing’s Sarcoma Eugenie S. Kleinerman, M.D.
Daniel Schneider
M.D./Ph.D. Program
Biochemistry and Molecular Biology
UTHealth Medical School
Role of Osteopontin and Adenosine Signaling in Chronic Pulmonary Disease Michael R. Blackburn, Ph.D.
Debra Smith
M.D./Ph.D. Program
Molecular Biology
Systems Biology
UTMDACC
Characterization of Akt Feedback in Cancer Gordon Mills, M.D., Ph.D.
Mary Anne Vincent
Ph.D. Program
Nursing
Center for Nursing Research
UTHealth School of Nursing
Biomarker Circadian Rhythm Profiles in Critically Ill Mechanically Ventilated Patients Sandra K. Hanneman, Ph.D., RN, FAAN

Year 3

Name/Program

Department

Project

Mentor

Jessica Bowser
Ph.D. Program
Cancer Biology
Pathology
UTMDACC
Targeting the Purinergic Pathway in Endometrial Cancer Russell Broaddus M.D., Ph.D.
Rene Colorado
MD/PhD Program
Neuroscience
Neuroscience
UTHealth Medical School
Combined fMRI and DTI to Demonstrate Structural Changes Associated with Cortical Reorganization in Multiple Sclerosis Ponnada Narayana, Ph.D.
Hatice Duzkale
Ph.D. Program
Genes and Development
Hematophathology
UTMDACC
Identification of the Role of LDOC1 in the Pathogenesis of Chronic Lymphocytic Leukemia (CLL) Lynne V. Abruzzo, M.D., Ph.D.
Hillary Gibbons
Ph.D. Program
Immunology
Immunology
UTMDACC
Transiently Modified T Cells Redirected to Tumor Antigen for Treatment of Diffuse Intrinsic Pontine Glioma Laurence Cooper, M.D., Ph.D.
Lenka Hurton
Ph.D. Program
Immunology
Immunology
UTMDACC
Improving Persistence of Tumor-specific T cells by Augmenting Signaling in Concert with Immunoreceptor for Improved Therapeutic Efficacy Laurence J.N. Cooper, M.D., Ph.D.
Cameron Jeter
Ph.D. Program
Neuroscience
Neuroscience
UTHealth Medical School
Reflexive and Voluntary Eye Movements in Tourette Syndrome Anne B. Sereno, Ph.D.
Audrey Nath
M.D./Ph.D. Program
Neuroscience
Neuroscience
UTHealth Medical School
Structural Equation Modeling and Multi-Voxel Pattern Analysis of fMRI Data as a Novel Measure of Multisensory Deficits in Dyslexic Readers Michael Beauchamp, Ph.D.
Sumaiyah Khaleel Rehman
Ph.D. Program
Cancer Biology
Molecular and Cellular Biology
UTMDACC
14-3-3ζ induced microRNA Deregulation in Early Breast Lesions Promotes Cancer Progression Dihua Yu, M.D., Ph.D.
Amy J. Reid
M.D./Ph.D. Program
Human and Molecular Genetics
Human and Molecular Genetics
UTHealth Medical Scho
Dysfunctional Differentiation of the Vascular Smooth Muscle Cells in Patients with Genetic Cerebrovascular Disease Dianna Milewicz, M.D., Ph.D.
Katrina Salazar
M.D./Ph.D. Program
Cancer Biology
Pathology
UTMDACC
Targeting the TGF-beta-TAZ Pathway in Glioblastoma Kenneth Aldape, M.D.
Keri Schadler
Ph.D. Program
Cancer Biology
Cancer Biology
UTMDACC
The Role of Delta-like Ligand 4 in Vasculogenesis in Ewing’s Sarcoma Eugenie S. Kleinerman, M.D.
Daniel Schneider
M.D./Ph.D. Program
Biochemistry and Molecular Biology
UTHealth Medical School
Role of Osteopontin and Adenosine Signaling in Chronic Pulmonary Disease Michael R. Blackburn, Ph.D.
Lisa Shiue
Ph.D. Program
Immunology
Dermatology
UTMDACC
Immunological Mechanisms of Extracorporeal Photopheresis in Cutaneous T-Cell Lymphoma versus Graft vs. Host Disease: Induction of Antigen-specific Cytotoxic T-cells or Regulatory T-cells? Madeleine Duvic, M.D.
Mary Anne Vincent
Ph.D. Program
Nursing
Center for Nursing Research
UTHealth School of Nursing
Biomarker Circadian Rhythm Profiles in Critically Ill Mechanically Ventilated Patients Sandra K. Hanneman, Ph.D., RN, FAAN
Jillian Frances Wise
Ph.D. Program
Immunology
Lymphoma/Myeloma
UTMDACC
Deciphering the Underlying Mechanism of Anti-CD74 Antibody (hLL1) Felipe Samaniego, M.D., MPH
Richard C. Wu
M.D./Ph.D. Program
Immunology
Melanoma Medical Oncology
UTMDACC
Functional Characterization of Novel Immunoregulatory CD8+CD27+CD28+CD57+ T Lymphocytes in Tumor-Infiltrating Lymphocytes in Human Cancers Laszlo Radvanyi, Ph.D.

 

KL2 Program

Director: Jon Tyson, MD, MPH
Contact persons: Michelle Smith 713-500-5651
                              

The CCTS KL2 program supports the training and career development of UT clinical fellows (with MD, DO, DDS, or DSN degrees) and of UT instructors and assistant professors (with MD, DO, DDS, DSN, PhD, RPh, or PharmD degrees) conducting clinical or translational research.  The program provides salary support  up to 75% of the total salary and $10,000 to $15,000 yearly for research and education costs.  Funding is for up to 2 years for fellows and up to 3 years for instructors and assistant professors.

All applicants must be engaged in or preparing to conduct clinical or translational research and must be able to complete the entire funding period at UTHealth.  Each applicant's department chair must confirm that the applicant will have protected time commensurate with the percent salary support the KL2 program will supply. (In calculating percent protected time, the denominator must be the total institutional activities for which an individual is compensated by his or her institution.  This includes time in house for patient care/call at night and on weekends.)  Applicants must be US citizens or permanent residents. 
 
Each trainee will conduct a research study under the supervision of a senior faculty mentor and complete the core curriculum at UTHealth Clinical Research Curriculum.  Trainees will also propose and complete individualized career development plans that include a statement of career goals and any additional training (beyond the core curriculum) that will be undertaken to complete them. 

THE KL2 PROGRAM IS CURRENTLY ACCEPTING APPLICATIONS. 

DEADLINE FOR SUBMISSION IS APRIL 5, 2013

PLEASE CONTACT Michelle Smith FOR MORE INFORMATION AND THE APPLICATION FORM.

Year 1

Name

Affiliation

Project

Mentors

Kenneth Helmer, MD, PhD Assistant Professor
Surgery
UTHealth Medical School
The Anti-Inflammatory Role of Ketamine in Thoracoabdominal Aortic Aneurysm Repair David Mercer, MD
Jon Tyson, MD, MPH
Mary Koenig, MD, PhD Fellow
Pediatrics
UTHealth Medical School
Contribution of Mitochondrial Membrane Uncoupling to Heteroplasmic Shift during Ketogenic Incubation of Mutated mDNA Cells in vitro Diane Hickson-Bick, PhD
Hope Northrup, MD
Elizabeth Plimack, MD Fellow
Cancer Medicine
UTMDACC
Efficacy and Toxicity of Decitabine Combined with IFN alfa-2b in Patients with Advanced RCC Jean-Pierre Issa, MD
Robert Wolff, MD
Mary Ruppe, MD, PhD Assistant Professor
Internal Medicine
UTHealth Medical School
Growth Determinants in X-Linked Hypophosphatemic Rickets Dianna Milewicz, MD, PhD
Kerri Smith, PhD Assistant Professor
Pathology
UTHealth Medical School
Induction of Tolerance Using a Covalent Analog of Factor VIII Keith Hoots, MD
Sudhir Paul, PhD
Wendy Woodward, MD, PhD Assistant Professor
Breast Radiation Oncology
UTMDACC
Radiation Resistance of Human Mammary Stem/Progenitor Cells in the Immortalized Human Breast Cancer Cell Line MCF-7 Thomas Buchholz, MD
Jeffrey Rosen, PhD


Year 2

NameAffiliationProjectMentors
Scott Evans, MD Assistant Professor
Pulmonary Medicine
UTMDACC
Evaluation of Pulmonary Epithelial Cells and Alveolar Macrophages Will Predict the Etiology of Infectious Pneumonias Burton Dickey, MD
Nicole Gonzales, MD Assistant Professor
Neurology
UTHealth
Medical School
A Pilot Trial of PPAR-y Agonist to Accelerate Hematoma Resolution in Intracerebral Hemorrhage James Grotta, MD
Jay Murthy, MD Assistant Professor 
Internal Medicine
UTHealth
Medical School
Comparative Expression Proteomics of Bronchoalveolar Lavage Fluid and Serum in Patients with Diffuse Systemic Sclerosis – Associated Interstitial Lung Disease and a Novel Scleroderma Mouse Model Michael Blackburn, PhD
Maureen D. Mayes, MD, MPH
Claudia Pedroza, PhD Assistant Professor
UTHealth 
School of Public Health
Use of Bayesian Methods for Analyses of Center Differences Jon Tyson, MD, MPH
Lemuel Moye, MD, PhD
Christopher Pelloski, MD Assistant Professor
Radiation Oncology
UTMDACC
Mechanisms and Prognostic Significance of YKL-40 Induced Gene Expression and Phenotypic Changes in Malignant Glioma Kenneth Aldape, MD
Alfred Y.K. Yung, MD
Amado Zurita, MD Assistant Professor Genitourinary Medical Oncology
UTMDACC
Developing Osteoblast Cadherin (Ob-Cadherin) as a Biomarker and Therapeutic Target in Prostate Cancer Metastasis Sue-Hwa Lin, PhD
John Heymach MD, PhD

Year 3

NameAffiliationProjectMentors
Jerrie Refuerzo, MD Assistant Professor
Obstetrics and Gynecology
UTHealth Medical School
Developing, Evaluating, and Applying Nanotherapeutics to Improve the Treatment of Outcome of High Risk Pregnancies Mauro Ferrari, PhD    
Erik Sulman, MD, PhD Assistant
Professor Radiation Oncology
UTMDACC
Functional Analysis of Podoplanin in the Treatment Resistance of Glioma Stem Cells  Kenneth Aldape, MD
Nitin Tandon, MD Assistant Professor Neurosurgery
UTHealth Medical School
A Cross-modal Synthetic Approach to Eloquent Cortical Regions Ponnada Narayana, PhD 
KuoJen Tsao, MD Assistant Professor Pediatric Surgery
UTHealth Medical School
The Role of Anti-reflux Surgery for Gastroesophageal reflux Disease in Premature Infants with Bronchopulmonary Dysplasia  Kevin Lally, MD
Kathleen Kennedy, MD, MPH
Susan Wootton, MD Assistant Professor Pediatrics
Infectious Diseases
UTHealth Medical School
GI Shedding of Human Influenza Virus in Hospitalized Children James Murphy, MD

Year 4

NameAffiliationProjectMentors
Sunil Krishnan, MD Assistant Professor
Radiation Oncology
Optimizing the combination of gold nanoparticles and radiation therapy John Hazle, PhD
Kevin Hwang, MD, MPH Assistant Professor
Internal Medicine
UTHealth Medical School
Promoting colorectal cancer screening among members of internet health communities Eric Thomas, MD, MPH
Shervin Assassi, MD Assistant Professor
Internal Medicine/
Rheumatology
UTHealth Medical School
Gene expression predictors of outcome in systemic sclerosis Filemon Tan, MD, MPH
Isabel Gay, DDS, MS Assistant Professor
Periodontics
UTHealth Dental Branch
The effect of non-surgical periodontal therapy on glycemic control of bacterial levels in a Mexican-American population with type 2 Diabetes Gena Triblle, PhD and James Katancik, DDS, PhD
*Jeremy Schaefer, PhD Instructor
Diagnostic Sciences UTHealth Dental Branch
Evaluation of miRNAs in peripheral blood leukocytes and intestine in Crohn’s disease patients: implication for diagnosis and therapy John Klein, PhD
*Shaper Mirza, PhD Assistant Professor
Epidemiology
UTHealth Medical School
Relationship between immune-dysregulation and nasal carriage of Streptococcus pneumoniae in elderly with type 2 diabetes mellitus and healthy control Susan Fisher-Hoch, MD
*CCTS Scholars funded by their institution/department

Year 5

NameAffiliationProjectMentors
Andrew Barreto, MD

Assistant Professor
Neurology UTHealth Medical School

The Safety and Efficacy of Argatroban and TPA in Acute Ischemic Stroke Jon Tyson, MD, MPH and James Grotta, MD
Laura Benjamins, MD, MPH Assistant Professor
Internal Medicine
UTHealth Medical School
Prevalence of Human Papillomavirus Infection among HIV-exposed infants Gloria Heresi, MD and James Murphy, PhD

CCTS Trainees, Scholars, and Associate Members Dinner

August 7, 2007

The CCTS’s T32 trainees, K12 scholars, and associate members (new investigators supported by the CCTS through other mechanisms) met August 7 to discuss their research and forge new collaborations.  Many were surprised at the common themes among studies being performed in difference CCTS institutions.  For instance, several M. D. Anderson and UTHealth investigators realized they all were addressing aspects of inflammation.

 


 Ashley group
 Eyal Muscal, MD
(above) John McAuliffe (T32 trainee and student in the PhD program in Patient-Based Biological Research; Sarcoma Medical Oncology, M. D. Anderson Cancer Center); Ashley Hood Jagar (T32 trainee; Neuroscience, UTHealth); Emily Jen (T32 trainee; Experimental Therapeutics, M. D. Anderson Cancer Center); Scott Evans, MD (K12 scholar; Pulmonary Medicine, M. D. Anderson Cancer Center); Sandeep Agarwal, MD (CCTS associate member; Rheumatology; UTHealth Medical School).  (above) Eyal Muscal, MD (CCTS associate member and student in the Masters Program in Clinical Research; Pediatrics/Rheumatology, Baylor College of Medicine), describes his studies on cognitive impairment in pediatric lupus. 
 
Eyal group
 Kamal Busaidy, DDS
(above) Eyal Muscal, MD (CCTS associate member and student in the Masters Program in Clinical Research; Pediatrics/Rheumatology, Baylor College of Medicine); Kenneth Helmer, MD (K12 scholar; Surgery, UTHealth Medical School); Lillian Kao, MD, MS (CCTS associate member and graduate of the Masters Program in Clinical Research; Surgery, UTHealth Medical School); Sherwin Assassi, MD (CCTS associate member and student in the Masters Program in Clinical Research; Rheumatology, UTHealth Medical School);  Frank Arnett, MD (Executive Director, CCTS); Jayasimha Murthy, MD (K12 scholar; Pulmonary and Critical Care Medicine, UTHealth Medical School).  (above) Kamal Busaidy, DDS (CCTS associate member and student in the Masters Program in Clinical Research; Oral Maxillofacial Surgery, UTHealth Dental Branch), discusses his work on osteonecrosis of the jaw due to bisphosphonate treatment, a therapy for some cancers.